PRN: Fed Shows Confidence in Market with Cut in Bond Buying Stimulus

01/mag/2014 13:33:16 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Fed Shows Confidence in Market with Cut in Bond Buying Stimulus


LONDON, May 1, 2014 /PRNewswire/ --

Top Five Stocks Focus List: Avanir Pharmaceuticals, Inc. Ins Pro Technologies Corp, Elite Pharmaceuticals, Inc. Nuvilex, Inc. Tranzbyte Corporation 

Although the volume remained light in trading to close the markets yesterday there was positive news in the form of the Fed reducing its bond buying stimulus on the back of a poor first quarter's results.  It goes to show the confidence the Fed have in the current market as the major indexes all closed higher for the day.  All eyes will be on the upcoming earnings quarter as we look to see if that confidence is backed up by corporate America.

Avanir Pharmaceuticals (NASDAQ: AVNR) was the strongest upside stock within the index to close trading yesterday up 48% on the day with more than 10 million shares traded.  Investors reacted positively to news about an upcoming trial and the stock was heavily traded throughout the day.  With the 52 week high within 20% of the closing price and the volume more than five times the normal average it looks like there could be continued heavy trading in today's session on the NASDAQ.

Ins Pro Technologies (OTCMKTS: ITCC) was certainly the most talked about stock in the OTC markets as the daily trading range was more than 500% in a stock that traded more than $2.4 million in a volatile day.  The upside was huge in the morning with shares opening around $0.06 and climbing to a high of $0.49.  The afternoon session however did bring some apparent profit taking in such a big move higher and Ins Pro was trading around $0.15 by the closing bell.  

If you are looking to receive our latest weekly picks as well as the latest news and volume trades sent directly to your inbox we invite you to sign up directly at Super Stock Profits.

Tranzbyte Corp (OTCMKTS: ERBB) traded more than 100 million shares in an active day for the stock to close trading on Wednesday.  Tranzbyte closed just below the high of the day and was higher by 8% on the trading day.  Traders have flocked to this name over the last couple of months with shares rising to a yearly high of $0.216.  Currently just under $0.04 the stock is looking to push through resistance to stand a chance of moving back to higher ground.

Elite Pharmaceuticals (OTCMKTS: ELTP) was another double digit gainer in Wednesdays trading with shares up over 14% and heavy action trading in the stock.  Shares were higher in the morning session with a slight pullback in the afternoon.  The 52 week high is within striking distance at $0.635 as traders continue to push this stock higher.

Nuvilex (OTCMKTS: NVLX) was lower by just a couple of percentage points in a lower than normal volume day for the stock that has an average of around 12 million shares.  Nuvilex is trading around the midpoint of its yearly trading range and after sliding around 20% over the last week it looks like shares could be at a low entry point for a move higher.

Super Stock Profits releases our daily trading report of the top trading volume and percentage leader plays within the small cap markets, keeping you up to date with the latest picks and the latest news on the stocks in focus.

Disclosure: Super Stock Profits is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities but for informational purposes only.  Investors should always conduct their own due diligence with any potential investment. Super Stock Profits is affiliated with AMG Global Advisors Ltd which is a FINRA registered company (168847). We have not been compensated by any of the companies listed in this news release.

Contact: Email:, Tel: +1-561-866-2256

Company Codes: NASDAQ-NMS:AVNR
blog comments powered by Disqus è un servizio offerto da Factotum Srl